Aarti Drugs Complete Financial Statements
AARTIDRUGS • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Aarti Drugs (AARTIDRUGS).
Downloads include all available records across all periods.
For market performance, see the
AARTIDRUGS stock price today
.
Profitability Ratios
Net Profit Margin
6.89%
2025 data
EBITDA Margin
12.86%
2025 data
Operating Margin
13.00%
2025 data
Return on Assets
1.75%
2025 data
Return on Equity
3.29%
2025 data
Balance Sheet Ratios
Current Ratio
3.64
2025 data
Debt to Equity
1.88
2025 data
Equity Ratio
53.17%
2025 data
Asset Turnover
0.25
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+8.8%
Year-over-Year
Net Profit Growth
+28.6%
Year-over-Year
EBITDA Growth
+21.7%
Year-over-Year
Expense Growth
+7.2%
Year-over-Year
Assets Growth
+5.9%
Year-over-Year
Equity Growth
+6.8%
Year-over-Year
Liabilities Growth
+5.9%
Year-over-Year
Operating Cash Flow Growth
-31.8%
Year-over-Year
Investing Cash Flow Growth
+26.3%
Year-over-Year
Financing Cash Flow Growth
+39.7%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Mar 2018 | Jun 2018 | Dec 2018 | Sept 2017 | Mar 2017 | Jun 2017 | Dec 2017 | Sept 2016 | Mar 2016 | Jun 2016 | Dec 2016 | Sept 2015 | Jun 2015 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 653 | 679 | 591 | 600 | 621 | 557 | 569 | 642 | 743 | 662 | 608 | 688 | 697 | 622 | 665 | 580 | 503 | 582 | 642 | 578 | 459 | 546 | 533 | 478 | 464 | 406 | 474 | 348 | 332 | 375 | 380 | 319 | 299 | 258 | 336 | 316 | 314 | 292 | 291 | 273 | 283 | 265 |
| Expenses | 569 | 583 | 516 | 531 | 534 | 490 | 495 | 565 | 649 | 577 | 536 | 614 | 608 | 555 | 593 | 506 | 421 | 500 | 545 | 462 | 378 | 411 | 425 | 409 | 403 | 351 | 410 | 300 | 274 | 322 | 328 | 267 | 253 | 223 | 282 | 265 | 269 | 244 | 247 | 230 | 240 | 226 |
| EBITDA | 84 | 95 | 74 | 69 | 87 | 66 | 74 | 77 | 94 | 85 | 72 | 74 | 89 | 67 | 72 | 74 | 82 | 81 | 97 | 117 | 81 | 135 | 108 | 69 | 61 | 55 | 64 | 47 | 57 | 54 | 52 | 53 | 46 | 36 | 54 | 51 | 45 | 48 | 43 | 42 | 44 | 40 |
| Operating Profit Margin % | 13.00% | 14.00% | 13.00% | 11.00% | 14.00% | 12.00% | 11.00% | 12.00% | 13.00% | 13.00% | 12.00% | 11.00% | 12.00% | 11.00% | 11.00% | 13.00% | 16.00% | 14.00% | 14.00% | 20.00% | 16.00% | 25.00% | 20.00% | 14.00% | 12.00% | 13.00% | 13.00% | 14.00% | 17.00% | 14.00% | 14.00% | 16.00% | 16.00% | 14.00% | 16.00% | 16.00% | 14.00% | 16.00% | 15.00% | 16.00% | 15.00% | 15.00% |
| Depreciation | 16 | 15 | 15 | 14 | 14 | 13 | 14 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 12 | 12 | 13 | 13 | 13 | 12 | 13 | 12 | 11 | 12 | 12 | 11 | 10 | 10 | 11 | 10 | 9 | 10 | 10 | 10 | 9 | 10 | 10 | 9 | 9 | 9 |
| Interest | 8 | 9 | 9 | 9 | 9 | 9 | 9 | 8 | 9 | 9 | 8 | 9 | 6 | 7 | 9 | 5 | 4 | 4 | 5 | 7 | 8 | 7 | 5 | 9 | 10 | 9 | 8 | 10 | 9 | 9 | 11 | 8 | 9 | 9 | 9 | 9 | 12 | 10 | 9 | 11 | 10 | 11 |
| Profit Before Tax | 60 | 71 | 51 | 46 | 64 | 44 | 51 | 56 | 73 | 64 | 52 | 53 | 71 | 48 | 50 | 56 | 65 | 65 | 79 | 97 | 61 | 116 | 90 | 48 | 40 | 34 | 43 | 27 | 38 | 34 | 31 | 35 | 31 | 17 | 35 | 33 | 25 | 29 | 24 | 23 | 25 | 23 |
| Tax | 15 | 8 | -3 | 11 | 17 | 11 | 14 | 17 | 17 | 16 | 15 | 14 | 15 | 13 | 13 | 14 | 14 | 16 | 20 | 22 | 2 | 31 | 22 | 16 | 12 | 11 | 15 | 9 | 14 | 10 | 10 | 11 | 9 | 5 | 12 | 11 | 6 | 9 | 6 | 7 | 8 | 6 |
| Net Profit | 45 | 63 | 54 | 35 | 47 | 33 | 37 | 40 | 56 | 48 | 37 | 39 | 55 | 35 | 37 | 43 | 52 | 49 | 58 | 75 | 59 | 85 | 68 | 32 | 27 | 23 | 28 | 18 | 24 | 23 | 21 | 24 | 22 | 11 | 23 | 22 | 19 | 20 | 18 | 16 | 17 | 17 |
| Earnings Per Share (₹) | 4.95 | 6.88 | 5.91 | 3.83 | 5.15 | 3.62 | 4.06 | 4.29 | 6.07 | 5.18 | 3.99 | 4.18 | 5.97 | 3.76 | 3.96 | 4.60 | 5.54 | 5.25 | 6.29 | 8.08 | 25.26 | 9.17 | 7.30 | 13.87 | 12.06 | 9.56 | 11.92 | 7.65 | 9.97 | 9.82 | 8.86 | 9.89 | 8.70 | 4.77 | 9.78 | 9.11 | 7.68 | 8.21 | 7.56 | 6.49 | 7.18 | 7.03 |
Related Pages for Aarti Drugs
Additional stock information and data for AARTIDRUGS
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 2,575 | 2,432 | 2,421 | 2,208 | 1,766 | 1,577 | 1,456 | 1,389 | 1,191 | 1,102 | 1,002 |
| Current Assets | 1,338 | 1,321 | 1,492 | 1,393 | 1,057 | 900 | 784 | 737 | 571 | 565 | 526 |
| Fixed Assets | 866 | 811 | 676 | 690 | 665 | 644 | 625 | 602 | 581 | 493 | 449 |
| Capital Work in Progress | 330 | 261 | 210 | 77 | 19 | 12 | 33 | 28 | 14 | 34 | 16 |
| Investments | 22 | 20 | 19 | 20 | 17 | 13 | 12 | 11 | 12 | 0 | 0 |
| Other Assets | 1,356 | 1,340 | 1,516 | 1,422 | 1,064 | 907 | 785 | 748 | 584 | 575 | 537 |
| LIABILITIES | |||||||||||
| Total Liabilities | 2,575 | 2,432 | 2,421 | 2,208 | 1,766 | 1,577 | 1,456 | 1,389 | 1,191 | 1,102 | 1,002 |
| Current Liabilities | 368 | 355 | 279 | 232 | 257 | 301 | 321 | 312 | 297 | 244 | 211 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 1,369 | 1,282 | 1,193 | 1,036 | 913 | 653 | 543 | 455 | 400 | 357 | 308 |
| Share Capital | 91 | 92 | 93 | 93 | 93 | 23 | 24 | 24 | 24 | 24 | 24 |
| Reserves & Surplus | 1,278 | 1,190 | 1,100 | 944 | 820 | 629 | 520 | 432 | 376 | 333 | 284 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 245 | 359 | 133 | 70 | 155 | 251 | 143 | 70 | 175 | 133 | 105 |
| Investing Activities | -165 | -224 | -164 | -150 | -72 | -33 | -62 | -74 | -107 | -99 | -107 |
| Financing Activities | -82 | -136 | 17 | 92 | -81 | -215 | -80 | 4 | -68 | -33 | 2 |
| Net Cash Flow | -2 | -1 | -14 | 13 | 2 | 2 | 1 | 0 | 0 | 1 | -1 |